BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morrison BH, Bauer JA, Hu J, Grane RW, Ozdemir AM, Chawla-Sarkar M, Gong B, Almasan A, Kalvakolanu DV, Lindner DJ. Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics. Oncogene. 2002;21:1882-1889. [PMID: 11896621 DOI: 10.1038/sj.onc.1205265] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Fassetti F, Leone O, Palopoli L, Rombo SE, Saiardi A. IP6K gene identification in plant genomes by tag searching. BMC Proc 2011;5 Suppl 2:S1. [PMID: 21554757 DOI: 10.1186/1753-6561-5-S2-S1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Thota SG, Bhandari R. The emerging roles of inositol pyrophosphates in eukaryotic cell physiology. J Biosci 2015;40:593-605. [PMID: 26333405 DOI: 10.1007/s12038-015-9549-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
3 Kalvakolanu DV. The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression. Cytokine Growth Factor Rev. 2004;15:169-194. [PMID: 15110800 DOI: 10.1016/j.cytogfr.2004.01.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
4 Minini M, Senni A, Unfer V, Bizzarri M. The Key Role of IP6K: A Novel Target for Anticancer Treatments? Molecules 2020;25:E4401. [PMID: 32992691 DOI: 10.3390/molecules25194401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ruan L, Xie Y, Liu F, Chen X. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study. European Journal of Obstetrics & Gynecology and Reproductive Biology 2018;222:31-8. [DOI: 10.1016/j.ejogrb.2018.01.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
6 Barker CJ, Berggren P, Fredholm BB. New Horizons in Cellular Regulation by Inositol Polyphosphates: Insights from the Pancreatic β -Cell. Pharmacol Rev 2013;65:641-69. [DOI: 10.1124/pr.112.006775] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
7 Rojas T, Cheng W, Gao Z, Liu X, Wang Y, Malla AP, Chin AC, Romer LH, Snyder SH, Fu C. Inositol hexakisphosphate kinase 3 promotes focal adhesion turnover via interactions with dynein intermediate chain 2. Proc Natl Acad Sci U S A 2019;116:3278-87. [PMID: 30718399 DOI: 10.1073/pnas.1817001116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Azevedo C, Szijgyarto Z, Saiardi A. The signaling role of inositol hexakisphosphate kinases (IP6Ks). Adv Enzyme Regul 2011;51:74-82. [PMID: 21035498 DOI: 10.1016/j.advenzreg.2010.08.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
9 Nagata E, Saiardi A, Tsukamoto H, Okada Y, Itoh Y, Satoh T, Itoh J, Margolis RL, Takizawa S, Sawa A, Takagi S. Inositol hexakisphosphate kinases induce cell death in Huntington disease. J Biol Chem 2011;286:26680-6. [PMID: 21652713 DOI: 10.1074/jbc.M111.220749] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
10 Plesca D, Mazumder S, Almasan A. DNA damage response and apoptosis. Methods Enzymol 2008;446:107-22. [PMID: 18603118 DOI: 10.1016/S0076-6879(08)01606-6] [Cited by in Crossref: 64] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
11 Xu Y, Li H, Bajrami B, Kwak H, Cao S, Liu P, Zhou J, Zhou Y, Zhu H, Ye K, Luo HR. Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate. Proc Natl Acad Sci U S A 2013;110:7726-31. [PMID: 23610437 DOI: 10.1073/pnas.1302906110] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
12 Kunzi MS, Pitha PM. Interferon Targeted Genes in Host Defense. Autoimmunity 2009;36:457-61. [DOI: 10.1080/08916930310001605855] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
13 Chakraborty A. The inositol pyrophosphate pathway in health and diseases. Biol Rev Camb Philos Soc 2018;93:1203-27. [PMID: 29282838 DOI: 10.1111/brv.12392] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
14 Nagata E, Luo HR, Saiardi A, Bae BI, Suzuki N, Snyder SH. Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death. J Biol Chem 2005;280:1634-40. [PMID: 15533939 DOI: 10.1074/jbc.M409416200] [Cited by in Crossref: 87] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
15 Cao CH, Ling H, Han K, Lu XP, Cai MY, Cao JH, Zhou J, Xiang ZC, Chen JW, Li S, Lin JL, Duan JL, Luo J, Fang YJ, Pan ZZ, Liang L, Wang F, Xie D, Wang FW. PPIP5K2 promotes colorectal carcinoma pathogenesis through facilitating DNA homologous recombination repair. Oncogene 2021. [PMID: 34645979 DOI: 10.1038/s41388-021-02052-5] [Reference Citation Analysis]
16 Onnebo SM, Saiardi A. Inositol pyrophosphates modulate hydrogen peroxide signalling. Biochem J 2009;423:109-18. [PMID: 19614566 DOI: 10.1042/BJ20090241] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
17 Wilson MC, Livermore T, Saiardi A. Inositol pyrophosphates: between signalling and metabolism. Biochemical Journal 2013;452:369-79. [DOI: 10.1042/bj20130118] [Cited by in Crossref: 166] [Cited by in F6Publishing: 100] [Article Influence: 18.4] [Reference Citation Analysis]
18 Barker CJ, Illies C, Gaboardi GC, Berggren PO. Inositol pyrophosphates: structure, enzymology and function. Cell Mol Life Sci 2009;66:3851-71. [PMID: 19714294 DOI: 10.1007/s00018-009-0115-2] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
19 Crocco P, Saiardi A, Wilson MS, Maletta R, Bruni AC, Passarino G, Rose G. Contribution of polymorphic variation of inositol hexakisphosphate kinase 3 ( IP6K3 ) gene promoter to the susceptibility to late onset Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2016;1862:1766-73. [DOI: 10.1016/j.bbadis.2016.06.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
20 Cervera A, Rantanen V, Ovaska K, Laakso M, Nuñez-fontarnau J, Alkodsi A, Casado J, Facciotto C, Häkkinen A, Louhimo R, Karinen S, Zhang K, Lavikka K, Lyly L, Pal Singh M, Hautaniemi S, Wren J. Anduril 2: upgraded large-scale data integration framework. Bioinformatics 2019;35:3815-7. [DOI: 10.1093/bioinformatics/btz133] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
21 Bhandari R, Juluri KR, Resnick AC, Snyder SH. Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis. Proc Natl Acad Sci U S A 2008;105:2349-53. [PMID: 18268345 DOI: 10.1073/pnas.0712227105] [Cited by in Crossref: 96] [Cited by in F6Publishing: 96] [Article Influence: 6.9] [Reference Citation Analysis]
22 Shah A, Ganguli S, Sen J, Bhandari R. Inositol Pyrophosphates: Energetic, Omnipresent and Versatile Signalling Molecules. J Indian Inst Sci 2017;97:23-40. [PMID: 32214696 DOI: 10.1007/s41745-016-0011-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
23 Saiardi A. Cell Signalling by Inositol Pyrophosphates. In: Balla T, Wymann M, York JD, editors. Phosphoinositides II: The Diverse Biological Functions. Dordrecht: Springer Netherlands; 2012. pp. 413-43. [DOI: 10.1007/978-94-007-3015-1_14] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
24 Kotredes KP, Gamero AM. Interferons as inducers of apoptosis in malignant cells. J Interferon Cytokine Res 2013;33:162-70. [PMID: 23570382 DOI: 10.1089/jir.2012.0110] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 7.7] [Reference Citation Analysis]
25 Vucenik I, Stains JP. Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad Sci. 2012;1271:37-43. [PMID: 23050962 DOI: 10.1111/j.1749-6632.2012.06750.x] [Cited by in Crossref: 332] [Cited by in F6Publishing: 293] [Article Influence: 36.9] [Reference Citation Analysis]
26 Koldobskiy MA, Chakraborty A, Werner JK Jr, Snowman AM, Juluri KR, Vandiver MS, Kim S, Heletz S, Snyder SH. p53-mediated apoptosis requires inositol hexakisphosphate kinase-2. Proc Natl Acad Sci U S A 2010;107:20947-51. [PMID: 21078964 DOI: 10.1073/pnas.1015671107] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
27 Holmes W, Jogl G. Crystal structure of inositol phosphate multikinase 2 and implications for substrate specificity. J Biol Chem 2006;281:38109-16. [PMID: 17050532 DOI: 10.1074/jbc.M606883200] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
28 Oikonomou E, Kothonidis K, Taoufik E, Probert E, Zografos G, Nasioulas G, Andera L, Pintzas A. Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo. Br J Cancer. 2007;97:73-84. [PMID: 17551494 DOI: 10.1038/sj.bjc.6603835] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
29 Chen LH, Liu XS, Wang WY, Han WN, Pan BR, Jin BQ. Localization of TRAIL/TRAILR in fetal pancreas. World J Gastroenterol 2003; 9(2): 334-337 [PMID: 12532461 DOI: 10.3748/wjg.v9.i2.334] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
30 Shears SB. Diphosphoinositol polyphosphates: metabolic messengers? Mol Pharmacol 2009;76:236-52. [PMID: 19439500 DOI: 10.1124/mol.109.055897] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 8.5] [Reference Citation Analysis]
31 Chakraborty A, Koldobskiy MA, Sixt KM, Juluri KR, Mustafa AK, Snowman AM, van Rossum DB, Patterson RL, Snyder SH. HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. Proc Natl Acad Sci U S A 2008;105:1134-9. [PMID: 18195352 DOI: 10.1073/pnas.0711168105] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
32 Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine & Growth Factor Reviews 2003;14:337-48. [DOI: 10.1016/s1359-6101(03)00029-7] [Cited by in Crossref: 400] [Cited by in F6Publishing: 160] [Article Influence: 21.1] [Reference Citation Analysis]
33 Sandström J, Balian A, Lockowandt R, Fornander T, Nordenskjöld B, Lindström L, Pérez-Tenorio G, Stål O. IP6K2 predicts favorable clinical outcome of primary breast cancer. Mol Clin Oncol 2021;14:94. [PMID: 33767863 DOI: 10.3892/mco.2021.2256] [Reference Citation Analysis]
34 Morrison BH, Tang Z, Jacobs BS, Bauer JA, Lindner DJ. Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma. Biochem J 2005;385:595-603. [PMID: 15634191 DOI: 10.1042/BJ20040971] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
35 Rachakatla RS, Pyle MM, Ayuzawa R, Edwards SM, Marini FC, Weiss ML, Tamura M, Troyer D. Combination Treatment of Human Umbilical Cord Matrix Stem Cell-Based Interferon-Beta Gene Therapy and 5-Fluorouracil Significantly Reduces Growth of Metastatic Human Breast Cancer in SCID Mouse Lungs. Cancer Investigation 2009;26:662-70. [DOI: 10.1080/07357900701871134] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
36 Morrison BH, Haney R, Lamarre E, Drazba J, Prestwich GD, Lindner DJ. Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma. Oncogene 2009;28:2383-92. [PMID: 19430495 DOI: 10.1038/onc.2009.113] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
37 Xu R, Sen N, Paul BD, Snowman AM, Rao F, Vandiver MS, Xu J, Snyder SH. Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death. Sci Signal 2013;6:ra22. [PMID: 23550211 DOI: 10.1126/scisignal.2003405] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
38 Chakraborty A, Kim S, Snyder SH. Inositol pyrophosphates as mammalian cell signals. Sci Signal 2011;4:re1. [PMID: 21878680 DOI: 10.1126/scisignal.2001958] [Cited by in Crossref: 105] [Cited by in F6Publishing: 111] [Article Influence: 9.5] [Reference Citation Analysis]
39 Machkalyan G, Hèbert TE, Miller GJ. PPIP5K1 Suppresses Etoposide-triggered Apoptosis. J Mol Signal 2016;11:4. [PMID: 31051014 DOI: 10.5334/1750-2187-11-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Thomas MP, Potter BV. The enzymes of human diphosphoinositol polyphosphate metabolism. FEBS J 2014;281:14-33. [PMID: 24152294 DOI: 10.1111/febs.12575] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
41 Prasad A, Jia Y, Chakraborty A, Li Y, Jain SK, Zhong J, Roy SG, Loison F, Mondal S, Sakai J, Blanchard C, Snyder SH, Luo HR. Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling. Nat Immunol 2011;12:752-60. [PMID: 21685907 DOI: 10.1038/ni.2052] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
42 Losito O, Szijgyarto Z, Resnick AC, Saiardi A. Inositol pyrophosphates and their unique metabolic complexity: analysis by gel electrophoresis. PLoS One 2009;4:e5580. [PMID: 19440344 DOI: 10.1371/journal.pone.0005580] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 6.5] [Reference Citation Analysis]
43 Oritani K, Kanakura Y. IFN-zeta/ limitin: a member of type I IFN with mild lympho-myelosuppression. J Cell Mol Med 2005;9:244-54. [PMID: 15963247 DOI: 10.1111/j.1582-4934.2005.tb00353.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
44 Rao F, Cha J, Xu J, Xu R, Vandiver MS, Tyagi R, Tokhunts R, Koldobskiy MA, Fu C, Barrow R, Wu M, Fiedler D, Barrow JC, Snyder SH. Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2. Mol Cell 2014;54:119-32. [PMID: 24657168 DOI: 10.1016/j.molcel.2014.02.020] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 7.6] [Reference Citation Analysis]
45 Morrison BH, Bauer JA, Lupica JA, Tang Z, Schmidt H, DiDonato JA, Lindner DJ. Effect of inositol hexakisphosphate kinase 2 on transforming growth factor beta-activated kinase 1 and NF-kappaB activation. J Biol Chem 2007;282:15349-56. [PMID: 17379600 DOI: 10.1074/jbc.M700156200] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]